A big market for rare conditionsBetween 2011 and 2013, a small Silicon Valley-based biotech company, Sequenom, tripled in size. The key to its success: MaterniT21, a new prenatal screening test that did remarkably well at detecting Down syndrome.Older screening tests took months and required multiple blood tests. This new one generated fewer false positives with…
